The patient, diagnostic, and treatment intervals in adult patients with cancer from high-and lower-income countries: A systematic review and meta-analysis

D Petrova, Z Špacírová, NF Fernández-Martínez… - PLoS …, 2022 - journals.plos.org
Background Longer time intervals to diagnosis and treatment are associated with worse
survival for various types of cancer. The patient, diagnostic, and treatment intervals are …

[HTML][HTML] The pancreas and COVID-19: a clinical conundrum

H Goyal, J Kopel, B Ristić, A Perisetti… - American Journal of …, 2021 - ncbi.nlm.nih.gov
With the progression of the COVID-19 pandemic, the classic manifestations of COVID-19
(eg, persistent fever, dry cough, pneumonia, and acute respiratory distress syndrome in the …

No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS‐COV‐2 outbreak: A retrospective multicenter cohort …

E Kempf, S Priou, G Lamé, A Laurent… - … Journal of Cancer, 2023 - Wiley Online Library
The SARS‐COV‐2 pandemic disrupted healthcare systems. We assessed its impact on the
presentation, care trajectories and outcomes of new pancreatic cancers (PCs) in the Paris …

Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models

P Elek, M Csanádi, P Fadgyas-Freyler, N Gervai… - BMJ open, 2022 - bmjopen.bmj.com
Objective During the COVID-19 pandemic, health system resources were reallocated to
provide care for patients with COVID-19, limiting access for others. Patients themselves also …

[HTML][HTML] Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience

SC McKay, S Pathak, RJW Wilkin, SK Kamarajah… - HPB, 2021 - Elsevier
Abstract Introduction The SARS-CoV-2 pandemic presented healthcare providers with an
extreme challenge to provide cancer services. The impact upon the diagnostic and treatment …

Time between pancreatic cancer diagnosis and treatment initiation and survival in the US Military Health System

YL Eaglehouse, S Darmon, AB Park, CD Shriver, K Zhu - Pancreatology, 2024 - Elsevier
Background Pancreatic cancer has a high case fatality and treatment is known to improve
survival. It is unknown whether the time between diagnosis and treatment initiation (time-to …

Wait times and breast cancer survival: a population-based retrospective cohort study using CanIMPACT data

R Walsh, A Lofters, P Groome, R Moineddin… - Cancer Causes & …, 2024 - Springer
Purpose The time from breast cancer surgery to chemotherapy has been shown to affect
survival outcomes; however, the effect of time from first breast cancer-related healthcare …

Defining and Understanding Diagnostic Delays Among Pancreatic Cancer Patients: A Retrospective Cohort Study

N Khalaf, Y Liu, JR Kramer, HB El-Serag… - Clinical …, 2025 - Elsevier
ABSTRACT Background and Aims: Pancreatic cancer is a lethal cancer of increasing
incidence, presenting with several clinically detectable signals allowing for earlier diagnosis …

Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic …

JG Pitter, M Moizs, ÉS Ezer, G Lukács, A Szigeti… - Plos one, 2022 - journals.plos.org
OnkoNetwork is a patient navigation program established in the Moritz Kaposi General
Hospital to improve the timeliness and completeness of cancer investigations and treatment …

Impact of biopsy attempts, race, and access on time to initiation of treatment for pancreatic cancer

RP Bohan, AN Riner, KM Herremans, H Gao… - Journal of …, 2023 - Elsevier
Background Biopsy of suspected pancreatic cancer (PDAC) in surgical candidates is
informative however not always necessary. Biopsies impact treatment options as histological …